|
rdf:type |
|
|
lifeskim:mentions |
|
|
pubmed:issue |
4
|
|
pubmed:dateCreated |
1993-11-22
|
|
pubmed:abstractText |
The anticardiolipin syndrome is characterized among other features by recurrent thromboembolic events, thrombocytopenia, and recurrent fetal loss associated with high IgG titers of anticardiolipin antibodies and/or the presence of lupus anticoagulant.
|
|
pubmed:language |
eng
|
|
pubmed:journal |
|
|
pubmed:citationSubset |
IM
|
|
pubmed:chemical |
|
|
pubmed:status |
MEDLINE
|
|
pubmed:month |
May
|
|
pubmed:issn |
1046-7408
|
|
pubmed:author |
|
|
pubmed:issnType |
Print
|
|
pubmed:volume |
29
|
|
pubmed:owner |
NLM
|
|
pubmed:authorsComplete |
Y
|
|
pubmed:pagination |
206-10
|
|
pubmed:dateRevised |
2006-11-15
|
|
pubmed:meshHeading |
pubmed-meshheading:8397810-Abortion, Habitual,
pubmed-meshheading:8397810-Animals,
pubmed-meshheading:8397810-Antibodies, Anticardiolipin,
pubmed-meshheading:8397810-Antibodies, Monoclonal,
pubmed-meshheading:8397810-Antiphospholipid Syndrome,
pubmed-meshheading:8397810-Chorionic Gonadotropin,
pubmed-meshheading:8397810-Female,
pubmed-meshheading:8397810-Humans,
pubmed-meshheading:8397810-Mice,
pubmed-meshheading:8397810-Models, Biological,
pubmed-meshheading:8397810-Placenta,
pubmed-meshheading:8397810-Pregnancy,
pubmed-meshheading:8397810-Pregnancy Complications,
pubmed-meshheading:8397810-Thromboembolism
|
|
pubmed:year |
1993
|
|
pubmed:articleTitle |
In vitro effect of anticardiolipin autoantibodies upon total and pulsatile placental hCG secretion during early pregnancy.
|
|
pubmed:affiliation |
Feto-Placental Endocrine Unit, Rappaport Institute, Technion, Haifa, Israel.
|
|
pubmed:publicationType |
Journal Article,
In Vitro,
Research Support, Non-U.S. Gov't
|
